Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

  1. Pro, B.
  2. Horwitz, S.M.
  3. Prince, H.M.
  4. Foss, F.M.
  5. Sokol, L.
  6. Greenwood, M.
  7. Caballero, D.
  8. Morschhauser, F.
  9. Wilhelm, M.
  10. Iyer, S.P.
  11. Shustov, A.R.
  12. Wolfson, J.
  13. Balser, B.E.
  14. Coiffier, B.
Journal:
Hematological Oncology

ISSN: 1099-1069 0278-0232

Year of publication: 2017

Volume: 35

Issue: 4

Pages: 914-917

Type: Letter

DOI: 10.1002/HON.2320 GOOGLE SCHOLAR lock_openOpen access editor